Predicting how HIV RNA behaves inside cells
Predictive modeling of viral RNA cellular behavior
Researchers are building tools to predict how HIV’s genetic material behaves in cells to help guide future treatments for people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11194256 on NIH RePORTER |
What this research studies
As someone affected by HIV, it's helpful to know that scientists will measure how HIV RNA and viral proteins move and change inside cells. They will combine high-throughput measurements, designed RNA mutations, and computer models to link molecular dynamics to viral function. The team will use the HIV 5'-leader RNA and the Gag protein as a model to study how the virus packages its genome and interacts with cell membranes. Ultimately they plan to use these insights to design new ways to target viral RNA with drugs.
Who could benefit from this research
Good fit: Ideal participants would be people living with HIV who are willing to provide blood or tissue samples or to be considered for future trials based on RNA-targeting approaches.
Not a fit: People without HIV, or those hoping for immediate new treatments, are unlikely to gain direct benefit from this basic laboratory-focused project.
Why it matters
Potential benefit: If successful, this work could enable new drugs that target HIV RNA dynamics to block viral assembly and lower viral levels.
How similar studies have performed: Prior laboratory studies have mapped RNA–protein interactions and support the approach, but translating quantitative RNA dynamics into therapies is still novel and experimental.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Ken, Megan L — Scripps Research Institute, the
- Study coordinator: Ken, Megan L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.